<p>根据 Citizens Financial Group Inc. RI 最近向证券交易委员会提交的 13F 文件，该公司在第二季度收购了 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免费报告）的新股份。该基金收购了 3,729 股公司股票，价值约为 276,000 美元。</p>
<ul>
<li>GE 航空航天：卡塔尔交易推动数十亿美元增长引擎</li>
</ul>
<p>其他大型投资者最近也买卖了该公司的股票。摩根大通在第一季度将其在 GE HealthCare Technologies 的股份增加了 49.9%。摩根大通目前拥有 5,140,549 股公司股票，价值 414,894,000 美元，在此期间又购买了 1,711,963 股。Nuveen LLC 在第一季度收购了价值 77,058,000 美元的 GE HealthCare Technologies 新股份。Eminence Capital LP 在第一季度将其在 GE HealthCare Technologies 的持股增加了 38.7%。Eminence Capital LP 目前拥有 1,819,129 股公司股票，价值 146,822,000 美元，在此期间又购买了 507,101 股。加拿大养老金计划投资委员会在第一季度将其在 GE HealthCare Technologies 的股份增加了 15.2%。加拿大养老金计划投资委员会目前拥有 3,111,398 股公司股票，价值 251,121,000 美元，在上个季度又购买了 409,636 股。最后，瑞穗市场开曼有限公司在第二季度收购了价值约 29,628,000 美元的 GE HealthCare Technologies 新股份。目前 82.06% 的股票由机构投资者持有。</p>
<h2>GE HealthCare Technologies 股票上涨 1.8%</h2>
<p>GEHC 股票周四开盘价为 72.31 美元。该股票的 50 日简单移动平均线为 74.77 美元，200 日简单移动平均线为 73.76 美元。GE HealthCare Technologies Inc.的 12 个月低点为 57.65 美元，12 个月高点为 94.80 美元。该公司的市值为 329.4 亿美元，市盈率为 14.94，市盈增长比率为 2.97，贝塔值为 1.13。该公司的速动比率为 0.95，流动比率为 1.18，债务与股本比率为 0.83。</p>
<ul>
<li>霍尼韦尔的拆分：HON 股票对投资者来说是个好交易吗？</li>
</ul>
<p>GE HealthCare Technologies（NASDAQ:GEHC - 获取免费报告）最近于 10 月 29 日（星期三）发布了季度财报。该公司报告季度每股收益为 1.07 美元，超出市场共识预期的 1.05 美元 0.02 美元。该公司季度收入为 51.4 亿美元，而分析师预期为 50.7 亿美元。GE HealthCare Technologies 的股本回报率为 22.52%，净利润率为 10.94%。与去年同期相比，该公司的收入增长了 5.8%。去年同期，该公司每股收益为 1.14 美元。GE HealthCare Technologies 已将其 2025 财年的指导目标设定为每股收益 4.510-4.630 美元。平均而言，股票分析师预测 GE HealthCare Technologies Inc.在当前财年将发布每股收益 4.68 美元。</p>
<h2>GE HealthCare Technologies 宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，已于 11 月 14 日（星期五）支付。10 月 24 日（星期五）登记的投资者获得了 0.035 美元的分红。除息日为 10 月 24 日（星期五）。这代表着年化分红为 0.14 美元，收益率为 0.2%。GE HealthCare Technologies 的派息比率目前为 2.89%。</p>
<h2>分析师设定新目标价</h2>
<ul>
<li>超声波减肥：GE HealthCare 与诺和诺德的合作</li>
</ul>
<p>一些股票研究分析师对该公司进行了评论。花旗集团在 10 月 7 日（星期二）的研究报告中将 GE HealthCare Technologies 的评级从 “买入” 下调至 “中性”，并将其目标价从 93.00 美元下调至 83.00 美元。巴克莱在 10 月 13 日（星期一）的研究报告中对 GE HealthCare Technologies 的股票进行了覆盖，给予 “持平” 评级和 86.00 美元的目标价。BTIG 研究在 10 月 29 日（星期三）的研究报告中设定了 GE HealthCare Technologies 的目标价为 87.00 美元。摩根士丹利在 10 月 30 日（星期四）将 GE HealthCare Technologies 的目标价从 74.00 美元上调至 80.00 美元，并给予该公司 “持平” 评级。最后，Evercore ISI 在 10 月 30 日（星期四）将 GE HealthCare Technologies 的目标价从 88.00 美元上调至 92.00 美元，并给予该股票 “跑赢大盘” 评级。六位投资分析师对该股票给予 “买入” 评级，六位分析师对该公司的股票给予 “持有” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 86.10 美元。</p>
<p><strong>获取我们对 GE HealthCare Technologies 的最新股票分析</strong></p>
<h2>GE HealthCare Technologies 简介</h2>
<p>（免费报告）</p>
<p>GE HealthCare Technologies Inc.从事产品、服务和补充数字解决方案的开发、制造和营销，这些产品、服务和解决方案用于美国、加拿大及国际上患者的诊断、治疗和监测。该公司通过四个部门运营：成像、超声、患者护理解决方案和药物诊断。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票比 GE HealthCare Technologies 更好</li>
<li>八月值得关注的三只最佳零售股票</li>
<li>onsemi 对其自身股票下注 60 亿美元</li>
<li>大盘股的定义及如何投资</li>
<li>HIMS 经历了过山车，投资者应该上车吗？</li>
<li>什么是二次公开募股？投资者需要知道什么</li>
<li>以这三只反弹冠军强势结束年末</li>
</ul>
<p><strong>想看看其他对 GEHC 持有股份的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 GE HealthCare Technologies 吗？</h2>
<p>在考虑 GE HealthCare Technologies 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 GE HealthCare Technologies 并不在名单上。</p>
<p>虽然 GE HealthCare Technologies 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

GEHC

<p>公民金融集团（Citizens Financial Group Inc.）在第二季度收购了 3,729 股 GE 医疗科技公司（GE HealthCare Technologies Inc.），价值 27.6 万美元。这项投资是机构投资于 GE 医疗的更广泛趋势的一部分。分析师对该股票的评级褒贬不一，有些分析师下调了评级，而另一些则提高了目标价。GE 医疗最近公布的季度收益超出预期，并宣布了分红。该股票的市值为 329.4 亿美元，82.06% 的股份由机构投资者持有</p>

<p>Citizens Financial Group Inc. RI acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,729 shares of the company's stock, valued at approximately $276,000.</p>
<div class="lb-trans"><p>根据 Citizens Financial Group Inc. RI 最近向证券交易委员会提交的 13F 文件，该公司在第二季度收购了 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免费报告）的新股份。该基金收购了 3,729 股公司股票，价值约为 276,000 美元。</p>
</div><ul>
<li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li>
</ul>
<div class="lb-trans"><ul>
<li>GE 航空航天：卡塔尔交易推动数十亿美元增长引擎</li>
</ul>
</div><p>Other large investors have also recently bought and sold shares of the company. JPMorgan Chase &amp; Co. lifted its stake in shares of GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase &amp; Co. now owns 5,140,549 shares of the company's stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the period. Nuveen LLC acquired a new stake in GE HealthCare Technologies in the first quarter worth $77,058,000. Eminence Capital LP grew its holdings in GE HealthCare Technologies by 38.7% in the first quarter. Eminence Capital LP now owns 1,819,129 shares of the company's stock worth $146,822,000 after purchasing an additional 507,101 shares during the period. Canada Pension Plan Investment Board increased its stake in GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company's stock valued at $251,121,000 after purchasing an additional 409,636 shares in the last quarter. Finally, Mizuho Markets Cayman LP acquired a new position in shares of GE HealthCare Technologies during the second quarter valued at about $29,628,000. 82.06% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他大型投资者最近也买卖了该公司的股票。摩根大通在第一季度将其在 GE HealthCare Technologies 的股份增加了 49.9%。摩根大通目前拥有 5,140,549 股公司股票，价值 414,894,000 美元，在此期间又购买了 1,711,963 股。Nuveen LLC 在第一季度收购了价值 77,058,000 美元的 GE HealthCare Technologies 新股份。Eminence Capital LP 在第一季度将其在 GE HealthCare Technologies 的持股增加了 38.7%。Eminence Capital LP 目前拥有 1,819,129 股公司股票，价值 146,822,000 美元，在此期间又购买了 507,101 股。加拿大养老金计划投资委员会在第一季度将其在 GE HealthCare Technologies 的股份增加了 15.2%。加拿大养老金计划投资委员会目前拥有 3,111,398 股公司股票，价值 251,121,000 美元，在上个季度又购买了 409,636 股。最后，瑞穗市场开曼有限公司在第二季度收购了价值约 29,628,000 美元的 GE HealthCare Technologies 新股份。目前 82.06% 的股票由机构投资者持有。</p>
</div><h2>GE HealthCare Technologies Stock Up 1.8%</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 股票上涨 1.8%</h2>
</div><p>GEHC stock opened at $72.31 on Thursday. The stock has a 50-day simple moving average of $74.77 and a two-hundred day simple moving average of $73.76. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The firm has a market capitalization of $32.94 billion, a PE ratio of 14.94, a PEG ratio of 2.97 and a beta of 1.13. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.</p>
<div class="lb-trans"><p>GEHC 股票周四开盘价为 72.31 美元。该股票的 50 日简单移动平均线为 74.77 美元，200 日简单移动平均线为 73.76 美元。GE HealthCare Technologies Inc.的 12 个月低点为 57.65 美元，12 个月高点为 94.80 美元。该公司的市值为 329.4 亿美元，市盈率为 14.94，市盈增长比率为 2.97，贝塔值为 1.13。该公司的速动比率为 0.95，流动比率为 1.18，债务与股本比率为 0.83。</p>
</div><ul>
<li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>霍尼韦尔的拆分：HON 股票对投资者来说是个好交易吗？</li>
</ul>
</div><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analysts' expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company's revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>GE HealthCare Technologies（NASDAQ:GEHC - 获取免费报告）最近于 10 月 29 日（星期三）发布了季度财报。该公司报告季度每股收益为 1.07 美元，超出市场共识预期的 1.05 美元 0.02 美元。该公司季度收入为 51.4 亿美元，而分析师预期为 50.7 亿美元。GE HealthCare Technologies 的股本回报率为 22.52%，净利润率为 10.94%。与去年同期相比，该公司的收入增长了 5.8%。去年同期，该公司每股收益为 1.14 美元。GE HealthCare Technologies 已将其 2025 财年的指导目标设定为每股收益 4.510-4.630 美元。平均而言，股票分析师预测 GE HealthCare Technologies Inc.在当前财年将发布每股收益 4.68 美元。</p>
</div><h2>GE HealthCare Technologies Announces Dividend</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 宣布分红</h2>
</div><p>The company also recently announced a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 24th were given a $0.035 dividend. The ex-dividend date was Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's payout ratio is presently 2.89%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，已于 11 月 14 日（星期五）支付。10 月 24 日（星期五）登记的投资者获得了 0.035 美元的分红。除息日为 10 月 24 日（星期五）。这代表着年化分红为 0.14 美元，收益率为 0.2%。GE HealthCare Technologies 的派息比率目前为 2.89%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><ul>
<li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li>
</ul>
<div class="lb-trans"><ul>
<li>超声波减肥：GE HealthCare 与诺和诺德的合作</li>
</ul>
</div><p>A number of equities research analysts have commented on the company. Citigroup cut GE HealthCare Technologies from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and reduced their price objective for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Barclays initiated coverage on shares of GE HealthCare Technologies in a research report on Monday, October 13th. They issued an &#34;equal weight&#34; rating and a $86.00 price target for the company. BTIG Research set a $87.00 price objective on shares of GE HealthCare Technologies in a research note on Wednesday, October 29th. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an &#34;equal weight&#34; rating in a report on Thursday, October 30th. Finally, Evercore ISI upped their target price on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an &#34;outperform&#34; rating in a report on Thursday, October 30th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $86.10.</p>
<div class="lb-trans"><p>一些股票研究分析师对该公司进行了评论。花旗集团在 10 月 7 日（星期二）的研究报告中将 GE HealthCare Technologies 的评级从 “买入” 下调至 “中性”，并将其目标价从 93.00 美元下调至 83.00 美元。巴克莱在 10 月 13 日（星期一）的研究报告中对 GE HealthCare Technologies 的股票进行了覆盖，给予 “持平” 评级和 86.00 美元的目标价。BTIG 研究在 10 月 29 日（星期三）的研究报告中设定了 GE HealthCare Technologies 的目标价为 87.00 美元。摩根士丹利在 10 月 30 日（星期四）将 GE HealthCare Technologies 的目标价从 74.00 美元上调至 80.00 美元，并给予该公司 “持平” 评级。最后，Evercore ISI 在 10 月 30 日（星期四）将 GE HealthCare Technologies 的目标价从 88.00 美元上调至 92.00 美元，并给予该股票 “跑赢大盘” 评级。六位投资分析师对该股票给予 “买入” 评级，六位分析师对该公司的股票给予 “持有” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 86.10 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on GE HealthCare Technologies</strong></p>
<div class="lb-trans"><p><strong>获取我们对 GE HealthCare Technologies 的最新股票分析</strong></p>
</div><h2>GE HealthCare Technologies Profile</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.</p>
<div class="lb-trans"><p>GE HealthCare Technologies Inc.从事产品、服务和补充数字解决方案的开发、制造和营销，这些产品、服务和解决方案用于美国、加拿大及国际上患者的诊断、治疗和监测。该公司通过四个部门运营：成像、超声、患者护理解决方案和药物诊断。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than GE HealthCare Technologies</li>
<li>The 3 Best Retail Stocks to Shop for in August</li>
<li>onsemi Places a $6 Billion Bet on Its Own Stock</li>
<li>Large Cap Stock Definition and How to Invest</li>
<li>HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?</li>
<li>What is a Secondary Public Offering? What Investors Need to Know</li>
<li>End the Year Strong With These 3 Comeback Champions</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 GE HealthCare Technologies 更好</li>
<li>八月值得关注的三只最佳零售股票</li>
<li>onsemi 对其自身股票下注 60 亿美元</li>
<li>大盘股的定义及如何投资</li>
<li>HIMS 经历了过山车，投资者应该上车吗？</li>
<li>什么是二次公开募股？投资者需要知道什么</li>
<li>以这三只反弹冠军强势结束年末</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding GEHC?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 GEHC 持有股份的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 GE HealthCare Technologies Inc.（NASDAQ:GEHC - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=GEHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 GE HealthCare Technologies 吗？</h2>
</div><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 GE HealthCare Technologies 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 GE HealthCare Technologies 并不在名单上。</p>
</div><p>While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 GE HealthCare Technologies 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Citizens Financial Group Inc. RI 在 GE HealthCare Technologies Inc. $GEHC 中新增了 27.6 万美元的投资